Humacyte Inc (HUMA)
6.33
-0.09
(-1.40%)
USD |
NASDAQ |
May 17, 16:00
6.35
+0.02
(+0.32%)
After-Hours: 20:00
Humacyte Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.031M |
| September 30, 2022 | 0.031M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.301M |
| March 31, 2022 | 0.233M |
| December 31, 2021 | 0.176M |
| September 30, 2021 | 0.24M |
| December 31, 2020 | 0.113M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2023
1.301M
Maximum
Jun 2022
0.1932M
Average
0.031M
Median
Sep 2022
Accounts Receivable (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 6.703M |
| Adial Pharmaceuticals Inc | -- |
| Gritstone Bio Inc | -- |
| Precision BioSciences Inc | 0.39M |
| Puma Biotechnology Inc | 24.58M |